Rimactane and cholestasis Patient Reports February 12, 2012

Rimactane Side Effects Report #5003895-6
Rimactane side effect was reported by a Health Professional from FRANCE on May 02, 2006. Female patient, 62 years of age, was diagnosed with sepsis  and was treated with Rimactane. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, haemolytic anaemia, inflammation, liver disorder. Rimactane dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PRIMAXIN, VITAMIN B1, INEXIUM, SPECIAFOLDINE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Rimactane Side Effects Report #5716169-2
Rimactane side effect was reported by a Physician from SWITZERLAND on Apr 10, 2008. Female patient, 55 years of age, weighting 176.4 lb, was diagnosed with bladder cancer , urinary tract infection  and was treated with Rimactane. After drug was administered, patient experienced the following side effects: bovine tuberculosis, bronchial hyperreactivity, cholestasis, condition aggravated, cytolytic hepatitis, liver injury, lung neoplasm, sepsis . Rimactane dosage: 600 MG, QD, ORAL. During the same period patient was treated with IMMUCYST, ROCEPHIN, RIMIFON, SIMCORA, PREDNISONE. Patient was hospitalized. Patient recovered.